UK Health Panel Spurns Prostate Cancer Screening Plan, Leaving Many Men Undiagnosed and Unprotected.
A panel of top British health experts has recommended that prostate cancer screening be reserved for only those men at the highest risk, sparking outrage among some charities and campaigners who feel that many more lives could have been saved. The National Screening Committee (UKNSC) says that while a targeted program for men with faulty BRCA1 or BRCA2 genes may lead to a small reduction in prostate cancer deaths, it will come at the cost of "very high levels" of over-diagnosis.
The UK is currently plagued by a lack of screening programs for prostate cancer, which affects one in eight men. However, experts have long warned that the PSA test used to detect prostate cancer is unreliable and could lead to unnecessary treatments. The UKNSC has taken this warning on board and concluded that screening all men would only lead to "a very large number of men being over-diagnosed".
Black men are particularly at risk from prostate cancer, but experts have been unable to gather sufficient evidence to support a targeted program for the group. This lack of data may be due in part to historical disparities in healthcare, which have left black men with poorer access to quality medical care.
Critics say that the UKNSC has missed an opportunity to make a "generational difference" in male health by excluding other groups from screening programs. Stephen Fry and Rishi Sunak have both expressed disappointment at the decision, while former Prime Minister David Cameron says he is "disappointed" that the government is not doing enough to push for wider screening.
The British government has vowed to examine the evidence behind the UKNSC's recommendation and will consult on the plan over the coming weeks. Health Secretary Wes Streeting said that the government aims to make progress on cutting cancer waiting times and investing in research into prostate cancer detection.
In contrast, Cancer Research UK says it "supports" the committee's conclusion that screening for all men would do more harm than good. The charity notes that modern evidence suggests that screening could miss dangerous cancers or detect ones that don't require treatment.
As a result of this decision, many men and their families will be left wondering why they are not being protected from one of the most common male cancers.
A panel of top British health experts has recommended that prostate cancer screening be reserved for only those men at the highest risk, sparking outrage among some charities and campaigners who feel that many more lives could have been saved. The National Screening Committee (UKNSC) says that while a targeted program for men with faulty BRCA1 or BRCA2 genes may lead to a small reduction in prostate cancer deaths, it will come at the cost of "very high levels" of over-diagnosis.
The UK is currently plagued by a lack of screening programs for prostate cancer, which affects one in eight men. However, experts have long warned that the PSA test used to detect prostate cancer is unreliable and could lead to unnecessary treatments. The UKNSC has taken this warning on board and concluded that screening all men would only lead to "a very large number of men being over-diagnosed".
Black men are particularly at risk from prostate cancer, but experts have been unable to gather sufficient evidence to support a targeted program for the group. This lack of data may be due in part to historical disparities in healthcare, which have left black men with poorer access to quality medical care.
Critics say that the UKNSC has missed an opportunity to make a "generational difference" in male health by excluding other groups from screening programs. Stephen Fry and Rishi Sunak have both expressed disappointment at the decision, while former Prime Minister David Cameron says he is "disappointed" that the government is not doing enough to push for wider screening.
The British government has vowed to examine the evidence behind the UKNSC's recommendation and will consult on the plan over the coming weeks. Health Secretary Wes Streeting said that the government aims to make progress on cutting cancer waiting times and investing in research into prostate cancer detection.
In contrast, Cancer Research UK says it "supports" the committee's conclusion that screening for all men would do more harm than good. The charity notes that modern evidence suggests that screening could miss dangerous cancers or detect ones that don't require treatment.
As a result of this decision, many men and their families will be left wondering why they are not being protected from one of the most common male cancers.